Ixazomib citrate

• Target:

  Proteasome|||Autophagy

• Related Pathways:

  Ubiquitination|||Proteases/Proteasome|||Autophagy

• Purity:

  >99.99%

• Bioactivity:

  Ixazomib citrate (MLN9708) is a prodrug of Ixazomib (MLN-2238) and an orally bioavailable second-generation proteasome inhibitor with an IC50 of 3.4 nM, exhibiting potential antineoplastic activity.

• Smiles:

  CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B1OC(=O)C(CC(O)=O)(CC(O)=O)O1

• Molecular Formula:

  C20H23BCl2N2O9

• Molecular Weight:

  517.12

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  1239908-20-3